SEC Form 4 · accession 0001104659-18-043858
Neos Therapeutics, Inc. · NEOS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Beth Hecht
Director
Period of report
Jul 2, 2018
Accepted (ET)
Jul 3, 2018 · 4:38 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001467652
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $6.05 | Jul 2, 2018 | A | 22,756 | A | — | Jul 2, 2028 | Common Stock | 22,756 | 22,756 | D |
Explanation of responses
- F1This stock option vests in equal quarterly installments over a one-year period which began on June 20, 2018.